Applied Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€103.82K - Cost of goods sold
€68.64K - Gross profit
-€79.79K - SG&A expenses
€57.61M - R&D expenses
€37.99M - EBITDA
-€95.32M - D&A
€247.10K - EBIT
-€95.57M - Interest expenses
€0.00 - EBT
-€58.12M - Tax expenses
€0.00 - Net income
-€58.12M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€34.73M - Changes in working capital
€9.81M - Operating cash flow
-€78.74M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
-€8.04M - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
-€78.74M - Cash at end of period
€26.10M - Free cash flow
-€78.74M
Balance sheet
- Cash and cash equivalents
€26.10M - Cash and short-term investments
€26.10M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€3.51M - Total current assets
€29.61M - Property, plant & equipment
€2.21M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€216.22K - Total non-current assets
€2.43M - Total assets
€32.04M - Accounts payable
€4.17M - Short-term debt
€383.53K - Other current liabilities
€10.67M - Total current liabilities
€15.23M - Long-term debt
€3.70M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.85M - Total liabilities
€17.08M - Common stock
€30.03K - Retained earnings
-€529.70M - Other equity
€0.00 - Total equity
€14.96M - Total liabilities and shareholders' equity
€32.04M
Company information
- Market capitalization
€39.10M - Employees
35 - Enterprise Value
€4.58M
Company ratios
- Gross margin
-
-76.9% Much better than peer group: -704.2% - EBITDA margin
-
-91,818.2% Much worse than peer group: -5,705.4% - EBIT margin
-
-92,056.2% Much worse than peer group: -5,838.4% - EBT margin
-
-55,982.6% Much worse than peer group: -5,771.8% - Net margin
-
-55,982.6% Much worse than peer group: -5,754.9% - ROE
-
-388.5% Much worse than peer group: -74.8% - ROA
-
-181.4% Much worse than peer group: -58.0% - Asset turnover
-
0.3% Even with peer group: 4.2% - FCF margin
-
-75,847.9% Much worse than peer group: -4,707.0% - FCF yield
-201.4% - Efficiency ratio
91,918.2% - Net sales per employee
-
€2.97K - Net income per employee
-
-€1.66M